Clinical Trial Results TV
September 22, 2010: Dr. Jean-Philippe Collet discusses the clinical trial CLOVIS-2: A Prospective, Randomized, Nested Case-Control Crossover
Dr. Jean-Philippe Collet discusses the clinical trial CLOVIS-2: A Prospective, Randomized,
Nested Case-Control Crossover Study of a High vs. Low Clopidogrel Loading Dose in
Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele at
TCT 2010.

Research Grants : BMS-Sanofi Aventis, Eli Lilly, Medtronic, Cordis ,Johnson&Johnson.
Consulting Fees : AstraZeneca, BMS, Daiichi Sankyo, Eli Lilly, Sanofi-Aventis. Lecture
Fees: AstraZeneca, BMS, Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis


[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
06-21-2018 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted